CERT

Certara, Inc.

Healthcare · $1.4B market cap

Share price

$9.36

close of Oct 3, 2026

Fair value

$11.88

Sticker Price

Payback Price

$4.75

buy price

Undervalued

CERT is Undervalued: at $9.36 it trades 21% below its fair value of $11.88. Its buy price (Payback Price) is $4.75, 49% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow Growth. There's too little earnings history to value it on earnings, but it has produced free cash flow consistently, so we value it on cash flow.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?

Equity per share growth-1.2% a year✗

Sales growth13.7% a year✓

Free cash flow growth22.1% a year✓

Return on invested capital-1.1%✗

Follow CERT

Get notified when it reaches its buy price of $4.75. Free.

Create a free account

Superinvestors

1 of the investors we track holds CERT. In Q2 2026, 1 opened a position. Who we track

First Eagle Investment Management

First Eagle Investment Management · as of Q2 2026

$3.4M

519,898 shares

Moves in Q2 2026

New position: First Eagle Investment Management

Insider activity

Since Sep 1, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

Mohammed Faiz

Interim CFO · 2026-09-01

Award

63,532 shares

About Certara, Inc.

Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative…

Medical - Healthcare Information Services